Indian CDMO Stocks Surge After US Passes Biosecure Act

Shares of Indian CDMO firms rallied on October 10 after the US Senate passed the Biosecure Act, restricting federal contracts with Chinese biotech companies.

Divi’s Labs, Piramal Pharma, and Wockhardt rose up to 5%. Analysts expect India’s CRAMS industry to gain significantly, supported by cost advantages, talent pool, and an eight-year transition period.